Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2020

Published	Pages	Publisher	Report code
Oct 2020	94	Global Markets Direct	ASDR-567854

Published: Oct 2020 - Pages : 94 - Publisher : Global Markets Direct - Report code : ASDR-567854

Asklepion Pharmaceuticals LLC
AstraZeneca Plc
Bristol-Myers Squibb Co
Cyclerion Therapeutics Inc
Global Blood Therapeutics Inc
GlycoMimetics Inc
Hartis Pharma SA
KM Biologics Co Ltd
NicOx SA
Novartis AG
Prolong Pharmaceuticals LLC

Sickle Cell Disease with Vaso-Occlusive Crisis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Sickle Cell Disease with Vaso-Occlusive Crisis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key P...

Published: September, 2022 | Report code: ASDR-610410